Feb. 2, 2018—The Affective Neuroscience Lab is recruiting healthy adults between the ages of 50-65 for a multiday study of the relation between brain chemistry and decision-making. The study involves tests of cognitive (thinking) ability, personality tests and brain imaging.
Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
Jan. 5, 2018—The Affective Neuroscience Lab in the Department of Psychology at Vanderbilt University is currently recruiting healthy male adults, 50–65 years old, for a multiday study that attempts to understand the relation between brain chemistry and decision-making.
Dec. 4, 2017—Vanderbilt senior Logan Brown has been named a Marshall Scholar for 2018, and senior Jacqueline (Jami) Cox has been named to the third class of Schwarzman Scholars, both organizations announced Monday.
Nov. 29, 2017—The first study to actually count the number of cortical neurons in the brains of a number of carnivores, including cats and dogs, has found that dogs possess significantly more of them than cats.
Neuroscientist Suzana Herculano-Houzel discusses the formation of remarkable brains—and minds—on ‘The Zeppos Report’
Oct. 16, 2017—The latest episode of the podcast features Associate Professor of Psychology and Biological Sciences Suzana Herculano-Houzel and the groundbreaking research featured in her book, "The Human Advantage."
Oct. 5, 2017—Vanderbilt anticipates the opportunity to nominate one candidate for the 2018 David Mahoney Neuroimaging Program of the Dana Foundation.
Sep. 28, 2017—The Affective Neuroscience Lab in the Department of Psychology at Vanderbilt University is currently recruiting healthy adults, 50–59 years old, for a multi-day study that attempts to understand the relation between brain chemistry and decision-making.
Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.
Aug. 25, 2017—New insights into the long-lasting effects of Fragile X syndrome on connections in the brain during early development highlight the importance of early detection and treatment.
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.